resources

Curis Lifesciences Ltd.

NSE: CURIS

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

121.00-3.0 (-2.42%)

21 Aug, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Curis Lifesciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2026
Annual Reports	—
Quarterly Results	Mar
Conference Calls	9Jan 29Jan
Presentations	11Mar

Corporate Announcements and Regulatory Filings

Curis Lifesciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under SEBI (Depositories and Participants) Regulations, 201819 Aug 2026
Curis Lifesciences Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th June, 2026
Agreements13 Aug 2026
Curis Lifesciences Limited has informed the Exchange about Joint venture agreement entered into by the company with CUROSUN PHARMACEUTICAL NIG LTD (Nigerian Company) by acquiring 49.95% stake of such company.
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter15 Jul 2026
Curis Lifesciences Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter and year ended on June 30, 2026
General Updates13 Jul 2026
Curis Lifesciences Limited has informed the Exchange about Comments of board on the fine levied by the National Stock Exchange (NSE Limited)
Appointment13 Jul 2026
Curis Lifesciences Limited has informed the Exchange regarding Appointment of Mr Devabhai Hamirbhai Jadeja as Non- Executive Independent Director of the company w.e.f. July 13, 2026.
Reply to Clarification- Financial results9 Jul 2026
The Exchange had sought clarification from Curis Lifesciences Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Cessation3 Jul 2026
Curis Lifesciences Limited has informed the Exchange regarding Cessation of Mr. Chand Rameshbhai Kanabar as Non- Executive Independent Director of the company w.e.f. July 03, 2026.
General Updates1 Jul 2026
Curis Lifesciences Limited has informed the Exchange about General Updates
Press Release23 Jun 2026
Curis Lifesciences Limited has informed the Exchange regarding a press release dated Jun 23, 2026, titled Press Release pertaining to audited financial results for the half year and yearended 31st March 2026.
Disclosure under SEBI Takeover Regulations2 Jun 2026
Curis Lifesciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Outcome of Board Meeting30 May 2026
Curis Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 30, 2026 regarding considering and approving the Audited Standalone Financial Results of the company for the half year and year ended on March 31, 2026.
Statement of deviation(s) or variation(s) under Reg. 3230 May 2026
Curis Lifesciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Integrated Filing- Financial30 May 2026
Outcome of Board Meeting held on May 30, 2026 to consider and approve the Audited Standalone Financial Results of the company for the half year and year ended on March 31, 2026.
Structural Digital Database30 May 2026
COMPLIANCE CERTIFICATE FOR THE YEAR ENDED 31ST MARCH, 2026
Updates11 May 2026
Curis Lifesciences Limited has informed the Exchange regarding 'Revised Confirmation on Non-Applicability of SEBI Circular on Large Corporates Initial Disclosure for FY 2026-27'.
Updates8 May 2026
Curis Lifesciences Limited has informed the Exchange regarding 'Confirmation on Non-Applicability of SEBI Circular on Large Corporates Initial Disclosure for FY 2026-27''.
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter23 Apr 2026
Curis Lifesciences Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter and year ended on March 31, 2026.
Certificate under SEBI (Depositories and Participants) Regulations, 201810 Apr 2026
Curis Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Resignation31 Mar 2026
Curis Lifesciences Limited has informed the Exchange regarding Resignation of Dhruvi Shyam Kapadia as Independent Director of the company w.e.f. April 01, 2026.
Resignation31 Mar 2026
Curis Lifesciences Limited has informed the Exchange regarding Resignation of Dhruvi Shyam Kapadia as Independent Director of the company w.e.f. April 01, 2026.

Frequently Asked Questions

Where can I download the annual report of Curis Lifesciences Ltd.?

Annual reports of Curis Lifesciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Curis Lifesciences Ltd.?

Quarterly earnings results and presentations of Curis Lifesciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Curis Lifesciences Ltd. publish earnings call transcripts?

Earnings call transcripts of Curis Lifesciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Curis Lifesciences Ltd.?

Investor presentations and annual day presentations of Curis Lifesciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Curis Lifesciences Ltd.?

Corporate announcements and regulatory filings of Curis Lifesciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Curis Lifesciences Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Curis Lifesciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Curis Lifesciences Ltd.?

The ISIN (International Securities Identification Number) of Curis Lifesciences Ltd. is INE1BZN01016. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Curis Lifesciences Ltd. listed?

Curis Lifesciences Ltd. is listed on NSE and BSE. The NSE symbol is CURIS and the BSE code is -.

Where can I find the shareholding pattern of Curis Lifesciences Ltd.?

The quarterly shareholding pattern of Curis Lifesciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Curis Lifesciences Ltd. on Sharpely?

Share price data for Curis Lifesciences Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.